Gene symbol | WT1 | Synonyms | AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1, WT33 | Type of gene | protein-coding |
Chromosome | 11 | Map location | 11p13 | dbXrefs | |
Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
Description | WT1 transcription factor |
GTO ID | GTC0148 |
Trial ID | NCT01621724 |
Disease | Acute Myeloid Leukemia | Chronic Myeloid Leukemia |
Altered gene | WT1 |
Therapeutic/Target gene | Target gene |
Therapy | TCR-T cell |
Treatment | WT1 TCR-T cells |
HLA | HLA-A*02:01 |
Phase | Phase1|Phase2 |
Recruitment status | Completed |
Title | WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study |
Year | 2012 |
Country | United Kingdom |
Company sponsor | Cell Medica Ltd |
Other ID(s) | D-00272-CT2014001|2006-004950-25 |
Vector information | |||||
|
Cohort1: dose level 1 | |||||||||||||||||
|
|||||||||||||||||
Cohort2: dose level 2 | |||||||||||||||||
|